SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-036632
Filing Date
2020-06-15
Accepted
2020-06-15 16:41:31
Documents
1
Period of Report
2020-06-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4002
  Complete submission text file 0001209191-20-036632.txt   5527
Mailing Address C/O CITIUS PHARMACEUTICALS, INC. 63 GREAT ROAD MAYNARD MA 01754
Business Address
HOLUBIAK MYRON Z (Reporting) CIK: 0001199080 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35005 | Film No.: 20963897

Mailing Address 331 OYSTER POINT BLVD. FOURTH FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 331 OYSTER POINT BLVD. FOURTH FLOOR SOUTH SAN FRANCISCO CA 94080 (833) 409-4583
ASSEMBLY BIOSCIENCES, INC. (Issuer) CIK: 0001426800 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations